Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial comparing ABP 501 to Adalimumab in adults with moderate to severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial comparing AM001 Cream to vehicle for plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis [Phase 4]
Phase 4 trial evaluating maintenance of treatment response in moderate plaque psoriasis with combination therapy of Olux E Foam (clobetasol …
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 clinical trial evaluating a subject-tailored maintenance dosing approach for ustekinumab in adults with moderate-to-severe plaque ps…
-
CLINICAL_TRIALS trial_result · 2016-11-03Clinical Trial Update: Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 clinical trial of generic tazarotene cream 0.05% for plaque psoriasis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis. [Phase 2]
Phase 2 study of R3421 in patients with moderate-to-severe chronic plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Skin Transcriptional Profiles In Psoriatic Patients Under Adalimumab Biotherapy [Phase 2]
Phase 2 trial evaluating skin transcriptional profiles in patients with chronic plaque psoriasis treated with adalimumab; study status is co…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis [Phase 2]
Pfizer's Phase 2 study of PF-04965842 for plaque psoriasis was terminated. The results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Adalimumab-psoriasis and Small Bowel Lesions [Phase 4]
Phase 4 clinical trial update indicating the study of adalimumab for plaque psoriasis and Crohn's disease with completion of the trial.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab [Phase 4]
Phase 4 trial updating etanercept treatment in patients with moderate to severe plaque psoriasis who lost response to adalimumab; study term…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis [Phase 4]
Phase 4 clinical trial evaluating ammonium lactate 12% lotion (Lac-Hydrin) and halobetasol propionate 0.05% ointment (Ultravate) for the tre…
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating ixekizumab delivery via auto-injector or prefilled syringe in adults with moderate to severe plaque psoriasis has c…
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Blinded Study of Topical Investigational Lotion Vs. Approved Cream in Treatment of Plaque Psoriasis [Phase 2]
Phase 2 blinded study comparing a topical investigational lotion to an approved cream for plaque psoriasis has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]
Phase 2 study evaluating multiple intravenous doses of AbGn-168H in patients with moderate to severe chronic plaque psoriasis; the trial has…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of halobetasol propionate lotion 0.05% in plaque psoriasis has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304) [Phase 3]
Phase 3 trial comparing 000-0551 Lotion to vehicle lotion in plaque psoriasis was completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis [Phase 3]
This document provides an update on a Phase 3 clinical trial evaluating Etanercept (Qiangke) for safety and efficacy in moderate-to-severe p…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis [Phase 1, Phase 2]
Safety and tolerability study of COVA322 in stable chronic moderate-to-severe plaque psoriasis was terminated after Phase 1/2, according to …
-
CLINICAL_TRIALS trial_result · 2016-01-06Clinical Trial Update: Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)
This update reports a completed Spain-based study (PROMISE) evaluating adalimumab (HUMIRA) for moderate-to-severe chronic plaque psoriasis, …
-
CLINICAL_TRIALS trial_result · 2016-01-05Clinical Trial Update: Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients [Phase 2]
Phase 2 trial evaluating a 12-month treatment with secukinumab in plaque psoriasis. The study assessed skin response and biomarkers and is r…
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients [Phase 3]
This document reports a Phase 3 efficacy trial comparing topical M518101 with Vitamin D3 for adults with plaque psoriasis. The trial has com…
-
CLINICAL_TRIALS trial_result · 2015-12-08Clinical Trial Update: Evaluate the Effect of Elimune Capsules [Phase 1]
Elorac's Phase 1 trial of Elimune Capsules for plaque psoriasis has completed, as indicated by the trial status.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: LAS41008 in Moderate to Severe Chronic Plaque Psoriasis [Phase 3]
Phase 3 study LAS41008 for moderate to severe plaque psoriasis has completed, as reported in the clinical trial update from Almirall.
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of M518101 in patients with plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis [Phase 3]
Phase 3 trial comparing secukinumab to etanercept in moderate to severe chronic plaque psoriasis completed with results posted in 2015.